BlackRock Japan’s Agios Pharmaceuticals AGIO Stock Holding History

BlackRock Japan’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-398	Closed	-$38K	–	1336
2015 Q1	$38K	Sell	398 -2,137	-84%	-$239K	﹤0.01%	1112
2014 Q4	$284K	Buy	+2,535	New	+$226K	﹤0.01%	826

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Japan's AGIO Position: Q2 2015 in Review

BlackRock Japan sold out of Agios Pharmaceuticals (AGIO) in Q2 2015, closing a stake of 398 shares — an estimated $38K sold.

BlackRock Japan first reported a position in AGIO in Q4 2014 and held it in 2 quarters. The position peaked at $284K in Q4 2014. 162 funds tracked by Wall St. Rank hold AGIO as of Q2 2015.

BlackRock Japan reported no remaining Agios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
BlackRock Japan sold 398 Agios Pharmaceuticals shares in Q2 2015, an estimated $38K.
BlackRock Japan first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 2 quarters.
BlackRock Japan's Agios Pharmaceuticals position peaked at $284K in Q4 2014.
162 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2015.

Based on BlackRock Japan's 13F filing for Q2 2015, filed 7 Aug 2015.